These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines. Nassal M; Skamel C; Vogel M; Kratz PA; Stehle T; Wallich R; Simon MM Int J Med Microbiol; 2008 Jan; 298(1-2):135-42. PubMed ID: 17888729 [TBL] [Abstract][Full Text] [Related]
29. Vaccination for Lyme disease: cost-effectiveness versus cost and value. Sigal LH Arthritis Rheum; 2002 Jun; 46(6):1439-42. PubMed ID: 12115172 [No Abstract] [Full Text] [Related]
30. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula. Nassal M; Skamel C; Kratz PA; Wallich R; Stehle T; Simon MM Eur J Immunol; 2005 Feb; 35(2):655-65. PubMed ID: 15668917 [TBL] [Abstract][Full Text] [Related]
31. By the way, doctor. I was vaccinated against Lyme disease in 2000. Do I still need to be careful about tick bites? Robb-Nicholson C Harv Womens Health Watch; 2006 Aug; 13(12):8. PubMed ID: 17120334 [No Abstract] [Full Text] [Related]
32. Lyme disease guidelines--it's time to move forward. Donta ST Clin Infect Dis; 2007 Apr; 44(8):1134-5; author reply 1137-9. PubMed ID: 17366465 [No Abstract] [Full Text] [Related]
33. [Death of a vaccine--the fall of LYMErix]. Zündorf I; Dingermann T Pharm Unserer Zeit; 2008; 37(1):38-9. PubMed ID: 18081078 [No Abstract] [Full Text] [Related]
34. Tick-host-pathogen interactions in Lyme borreliosis. Hovius JW; van Dam AP; Fikrig E Trends Parasitol; 2007 Sep; 23(9):434-8. PubMed ID: 17656156 [TBL] [Abstract][Full Text] [Related]
36. Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains. Earnhart CG; Buckles EL; Marconi RT Vaccine; 2007 Jan; 25(3):466-80. PubMed ID: 16996663 [TBL] [Abstract][Full Text] [Related]
37. [Lyme borreliosis--the most frequent vector-borne infection in Denmark]. Lebech AM; Hansen K Ugeskr Laeger; 2004 Jun; 166(25):2431-3. PubMed ID: 15283107 [No Abstract] [Full Text] [Related]
38. Concerns regarding the Infectious Diseases Society of America Lyme disease clinical practice guidelines. Wilson JM Clin Infect Dis; 2007 Apr; 44(8):1135-7; author reply 1137-9. PubMed ID: 17366466 [No Abstract] [Full Text] [Related]
39. Strategies for primary and secondary prevention of Lyme disease. Corapi KM; White MI; Phillips CB; Daltroy LH; Shadick NA; Liang MH Nat Clin Pract Rheumatol; 2007 Jan; 3(1):20-5. PubMed ID: 17203005 [TBL] [Abstract][Full Text] [Related]
40. Accuracy of recommendations in the Infectious Diseases Society of America clinical practice guidelines for Lyme disease. Pollock AA Clin Infect Dis; 2007 Apr; 44(8):1135; author reply 1137-9. PubMed ID: 17366467 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]